This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976-1983.
Company Filing History:
Years Active: 1976-1983
Title: Hubert Georg Seliger: Innovator in Chemotherapeutic Agents
Introduction
Hubert Georg Seliger is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of chemotherapeutic agents, particularly through his innovative patents. With a total of 2 patents, Seliger's work has had a profound impact on antimicrobial treatments.
Latest Patents
Seliger's latest patents include groundbreaking research on cephem derivatives. These compounds are characterized by a specific formula that includes various functional groups, making them valuable chemotherapeutic agents. They exhibit powerful antimicrobial action against both Gram-positive and Gram-negative bacteria, as well as effective action against penicillinase-forming Staphylococci. Another significant patent involves tetrahydroacridones, which have chemotherapeutic properties and can be used as drugs against protozoan diseases.
Career Highlights
Seliger is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on developing innovative compounds that address critical health challenges.
Collaborations
Throughout his career, Seliger has collaborated with esteemed colleagues such as Walter Durckheimer and Wolfgang Raether. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Hubert Georg Seliger's contributions to the field of chemotherapeutic agents highlight his innovative spirit and dedication to improving healthcare. His patents continue to influence the development of effective treatments for various bacterial and protozoan infections.